The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid

Clinical and Experimental Allergy

Volumn 46, Issue 2, 2016, Pages 264-274

  Torres, M J ^a   Montanez M I ^a,b   Ariza, A ^a   Salas, M ^a   Fernandez, T D ^a   Barbero, N ^b,c   Mayorga, C ^a   Blanca, M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CLAVULANIC ACID; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; ANTIINFECTIVE AGENT;

ANTIGENICITY; CHEMICAL STRUCTURE; DRUG CONJUGATION; DRUG HYPERSENSITIVITY; DRUG PROVOCATION TEST; DRUG TOLERANCE; HUMAN; IMMUNOCHEMISTRY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEOMICS; PROVOCATION TEST; REVIEW; SKIN TEST; IMMUNOLOGY;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLAVULANIC ACID; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E;

EID: 84955613309     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12689     Document Type: Review

References (82)

1. Edwards RG, Dewdney JM, Dobrzanski RJ, Lee D. Immunogenicity and allergenicity studies on two beta-lactam structures, a clavam, clavulanic acid, and a carbapenem: structure-activity relationships. Int Arch Allergy Appl Immunol 1988; 85:184-9.
2. Ferech M, Coenen S, Dvorakova K etal. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 2006; 58:408-12.
3. Antúnez C, Martín E, Cornejo-García JA etal. Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des 2006; 12:3327-33.
4. Rodriguez-Pena R, Antunez C, Martin E, Blanca-Lopez N, Mayorga C, Torres MJ. Allergic reactions to β-lactams. Expert Opin Drug Saf 2006; 5:31-48.
5. Adkinson NF Jr, Saxon A, Spence MR, Swabb EA. Cross-allergenicity and immunogenicity of aztreonam. Rev Infect Dis 1985; 7 (Suppl. 4):S613-21.
6. Ozcengiz G, Demain AL. Recent advances in the biosynthesis of penicillins, cephalosporins and clavams and its regulation. Biotechnol Adv 2013; 31:287-311.
7. Dona I, Blanca-Lopez N, Torres MJ etal. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012; 22:363-71.
8. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009; 122:778.e1-7.
9. Blanca M, Vega JM, Garcia J etal. Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to beta-lactams. Clin Exp Allergy 1990; 20:475-81.
10. Torres MJ, Blanca M, Fernandez J etal. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-72.
11. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of β-lactam hypersensitivity. Clin Exp Allergy 2008; 38:185-90.
12. Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 2013; 68:1057-64.
13. Romano A, Gaeta F, Valluzzi RL etal. IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015; 136:685-91.e3.
14. Fernandez-Rivas M, Perez Carral C, Cuevas M, Marti C, Moral A, Senent CJ. Selective allergic reactions to clavulanic acid. J Allergy Clin Immunol 1995; 95:748-50.
15. Blanca-Lopez N, Perez-Alzate D, Ruano F etal. Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis. Allergy 2015; 70:1013-9.
16. Torres MJ, Ariza A, Mayorga C etal. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010; 125:502-05.e2.
17. Cahen YD, Wuthrich B. Drug allergy to the beta-lactam antibiotics clavulanic acid and amoxicillin. Allergy 1997; 52:117-8.
18. Sanchez-Morillas L, Perez-Ezquerra PR, Reano-Martos M, Laguna-Martinez JJ, Sanz ML, Martinez LM. Selective allergic reactions to clavulanic acid: a report of 9 cases. J Allergy Clin Immunol 2010; 126:177-9.
19. Montañez MI, Ariza A, Mayorga C, Fernandez T, Torres M. Cross-Reactivity in Betalactam Allergy: Alternative Treatments. Curr Treat Options Allergy 2015; 2:141-54.
20. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014; 133:790-6.
21. Zambonino MA, Corzo JL, Munoz C etal. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol 2014; 25:80-7.
22. Antúnez C, Fernández T, Blanca-Lopez N etal. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Allergy 2006; 61:940-6.
23. Fukushima H, Misaki R, Takeuchi M, Niinomi Y, Harada M. Mouse anti-benzylpenicilloyl IgE monoclonal antibody: preparation, characterization and cross-reactivity. Clin Exp Immunol 1987; 68:427-36.
24. de Haan P, de Jonge AJ, Verbrugge T, Boorsma DM. Three epitope-specific monoclonal antibodies against the hapten penicillin. Int Arch Allergy Appl Immunol 1985; 76:42-6.
25. Mayorga C, Obispo T, Jimeno L etal. Epitope mapping of beta-lactam antibiotics with the use of monoclonal antibodies. Toxicology 1995; 97:225-34.
26. Montañez MI, Najera F, Mayorga C etal. Recognition of multiepitope dendrimeric antigens by human immunoglobulin E. Nanomedicine 2015; 11:579-88.
27. Blanca M, Perez E, Garcia J etal. Anaphylaxis to amoxycillin but good tolerance for benzyl penicillin. In vivo and invitro studies of specific IgE antibodies. Allergy 1988; 43:508-10.
28. Blanca M, Vega JM, Garcia J etal. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clin Exp Allergy 1994; 24:407-15.
29. Moreno F, Blanca M, Mayorga C etal. Studies of the specificities of IgE antibodies found in sera from subjects with allergic reactions to penicillins. Int Arch Allergy Immunol 1995; 108:74-81.
30. Blanca M, Torres MJ, García JJ etal. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103:918-24.
31. Torres MJ, Padial A, Mayorga C etal. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004; 34:1768-75.
32. Fernández TD, Torres MJ, Blanca-López N etal. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009; 64:242-8.
33. Gonzalez de Olano D, Losada PA, Caballer Bde L, Vazquez Gonzalez AC, Dieguez Pastor MC, Cuevas Agustin M. Selective sensitization to clavulanic acid and penicillin V. J Investig Allergol Clin Immunol 2007; 17:119-21.
34. Longo N, Gamboa PM, Gastaminza G etal. Diagnosis of clavulanic acid allergy using basophil activation and leukotriene release by basophils. J Investig Allergol Clin Immunol 2008; 18:473-5.
35. Mochizuki A, McEuen AR, Buckley MG, Walls AF. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. J Allergy Clin Immunol 2003; 112:102-8.
36. Miura K, MacGlashan DW. Phosphatidylinositol-3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils. Blood 2000; 96:2199-205.
37. Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935; 61:643-56.
38. Montañez MI, Torres MJ, Perez-Inestrosa E, Blanca M. Clarification concerning amoxicillin skin testing. J Allergy Clin Immunol 2011; 128:685.
39. Torres MJ, Romano A, Mayorga C etal. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56:850-6.
40. Lin E, Saxon A, Riedl M. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 2010; 152:313-8.
41. Torres MJ, Romano A, Blanca-Lopez N etal. Immunoglobulin E-mediated hypersensitivity to amoxicillin: invivo and invitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy 2011; 41:1595-601.
42. Blanca M, Romano A, Torres MJ etal. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64:183-93.
43. Bousquet PJ, Co-Minh HB, Arnoux B, Daures JP, Demoly P. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. J Allergy Clin Immunol 2005; 115:1314-6.
44. Torres MJ, Ariza A, Fernandez J etal. Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy 2010; 65:590-6.
45. Blanca M, Mayorga C, Torres MJ etal. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001; 56:862-70.
46. Sanz ML, Gamboa PM, Antepara I etal. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32:277-86.
47. Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A. High serum beta-lactams specific/total IgE ratio is associated with immediate reactions to beta-lactams antibiotics. PLoS ONE 2015; 10:e0121857.
48. Macy E, Goldberg B, Poon K-YT. Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy. Ann Allergy Asthma Immunol 2010; 105:136-41.
49. Aranda A, Mayorga C, Ariza A etal. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011; 66:247-54.
50. Gómez E, Blanca-Lopez N, Torres MJ etal. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-24.
51. Tortajada Girbes M, Ferrer Franco A, Gracia Antequera M, Clement Paredes A, Garcia Munoz E, Tallon Guerola M. Hypersensitivity to clavulanic acid in children. Allergol Immunopathol (Madr) 2008; 36:308-10.
52. Park BK, Tingle MD, Grabowski PS, Coleman JW, Kitteringham NR. Drug-protein conjugates-XI. Disposition and immunogenicity of dinitrofluorobenzene, a model compound for the investigation of drugs as haptens. Biochem Pharmacol 1987; 36:591-9.
53. Lee D, Dewdney JM, Edwards RG. The influence of hapten density on the assay of penicilloylated proteins in fluids. J Immunol Methods 1985; 84:235-43.
54. Baggaley KH, Brown AG, Schofield CJ. Chemistry and biosynthesis of clavulanic acid and other clavams. Nat Prod Rep 1997; 14:309-33.
55. Ariza A, Mayorga C, Fernandez TD etal. Hypersensitivity reactions to beta-lactams: relevance of hapten-protein conjugates. J Investig Allergol Clin Immunol 2015; 25:12-25.
56. Perez-Inestrosa E, Suau R, Montanez MI etal. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol 2005; 5:323-30.
57. Levine BB, Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J Exp Med 1961; 114:875-904.
58. Batchelor FR, Dewdney JM, Gazzard D. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965; 206:362-4.
59. Yvon M, Anglade P, Wal JM. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Lett 1990; 263:237-40.
60. Yvon M, Wal J-M. Identification of lysine residue 199 of human serum albumin as a binding site for benzylpenicilloyl groups. FEBS Lett 1988; 239:237-40.
61. Martin J, Mendez R, Alemany T. Studies on clavulanic acid. Part 1. Stability of clavulanic acid in aqueous solutions of amines containing hydroxy groups. J Chem Soc, Perkin Trans 2 1989; 223-6. DOI: 10.1039/p29890000223
62. Brethauer S, Held M, Panke S. Clavulanic acid decomposition is catalyzed by the compound itself and by its decomposition products. J Pharm Sci 2008; 97:3451-5.
63. Finn MJ, Harris MA, Hunt E, Zomaya II. Studies on the hydrolysis of clavulanic acid. J Chem Soc, Perkin Trans 1 1984; 1345-9. DOI: 10.1039/P19840001345
64. Tremblay LW, Hugonnet JE, Blanchard JS. Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate. Biochemistry 2008; 47:5312-6.
65. Sulton D, Pagan-Rodriguez D, Zhou X etal. Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition. J Biol Chem 2005; 280:35528-36.
66. Garzon D, Ariza A, Regazzoni L etal. Mass spectrometric strategies for the identification and characterization of human serum albumin covalently adducted by amoxicillin: exvivo studies. Chem Res Toxicol 2014; 27:1566-74.
67. Ariza A, Garzon D, Abanades DR etal. Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum. J Proteomics 2012; 77:504-20.
68. Meng X, Jenkins RE, Berry NG etal. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther 2011; 338:841-9.
69. Whitaker P, Meng X, Lavergne SN etal. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J Immunol 2011; 187:200-11.
70. Jenkins RE, Meng X, Elliott VL, Kitteringham NR, Pirmohamed M, Park BK. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA invitro and invivo. Proteomics Clin Appl 2009; 3:720-9.
71. El-Ghaiesh S, Monshi MM, Whitaker P etal. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther 2012; 341:597-610.
72. Fasano M, Curry S, Terreno E etal. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005; 57:787-96.
73. Yvon M, Anglade P, Wal JM. Binding of benzyl penicilloyl to human serum albumin. Evidence for a highly reactive region at the junction of domains 1 and 2 of the albumin molecule. FEBS Lett 1989; 247:273-8.
74. Ariza A, Collado D, Vida Y etal. Study of protein haptenation by amoxicillin through the use of a biotinylated antibiotic. PLoS ONE 2014; 9:e90891.
75. Carlier M, Stove V, Roberts JA, Van de Velde E, De Waele JJ, Verstraete AG. Quantification of seven beta-lactam antibiotics and two beta-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method. Int J Antimicrob Agents 2012; 40:416-22.
76. Reyns T, De Boever S, Baert K etal. Disposition and oral bioavailability of amoxicillin and clavulanic acid in pigs. J Vet Pharmacol Ther 2007; 30:550-5.
77. Carlier M, Noe M, De Waele JJ etal. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients. J Antimicrob Chemother 2013; 68:2600-8.
78. Arancibia A, Guttmann J, Gonzalez G, Gonzalez C. Absorption and disposition kinetics of amoxicillin in normal human subjects. Antimicrob Agents Chemother 1980; 17:199-202.
79. Sjovall J, Alvan G, Huitfeldt B. Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers. Br J Clin Pharmacol 1986; 21:171-81.
80. Sjovall J, Alvan G, Westerlund D. Dose-dependent absorption of amoxycillin and bacampicillin. Clin Pharmacol Ther 1985; 38:241-50.
81. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in Antimicrobial Drug Development: Implications for the Future. Clin Infect Dis 2004; 38:1279-86.
82. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 1999; 12:439-46.